{
  "DOI": "10.1007/s10689-014-9739-y",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-014-9739-y",
  "alternative-id": [
    "9739"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Zhang",
      "given": "Zhu",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Zhou",
      "given": "Bin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Gao",
      "given": "Qianqian",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wu",
      "given": "Yuke",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zhang",
      "given": "Kui",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Pu",
      "given": "Yan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Song",
      "given": "Yaping",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zhang",
      "given": "Lin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Xi",
      "given": "Mingrong",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2014,
        9,
        6
      ]
    ],
    "date-time": "2014-09-06T10:54:53Z",
    "timestamp": 1410000893000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        30
      ]
    ],
    "date-time": "2019-05-30T17:46:13Z",
    "timestamp": 1559238373000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        11,
        14
      ]
    ],
    "date-time": "2023-11-14T11:53:57Z",
    "timestamp": 1699962837702
  },
  "is-referenced-by-count": 14,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2014,
        9,
        7
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2014,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2014,
            9,
            7
          ]
        ],
        "date-time": "2014-09-07T00:00:00Z",
        "timestamp": 1410048000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-014-9739-y.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-014-9739-y/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-014-9739-y",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "595-601",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2014,
        9,
        7
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2014,
        9,
        7
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2014,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.3322/caac.21166",
      "author": "R Siegel",
      "doi-asserted-by": "crossref",
      "first-page": "11",
      "issue": "1",
      "journal-title": "CA Cancer J Clin",
      "key": "9739_CR1",
      "unstructured": "Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63(1):11–30. doi: 10.3322/caac.21166",
      "volume": "63",
      "year": "2013"
    },
    {
      "DOI": "10.1016/S0140-6736(09)61157-0",
      "author": "N Katsumata",
      "doi-asserted-by": "crossref",
      "first-page": "1331",
      "issue": "9698",
      "journal-title": "Lancet",
      "key": "9739_CR2",
      "unstructured": "Katsumata N, Yasuda M, Takahashi F, Isonishi S, Jobo T, Aoki D, Tsuda H, Sugiyama T, Kodama S, Kimura E, Ochiai K, Noda K (2009) Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial. Lancet 374(9698):1331–1338. doi: 10.1016/S0140-6736(09)61157-0",
      "volume": "374",
      "year": "2009"
    },
    {
      "DOI": "10.1200/JCO.2012.42.0505",
      "author": "C Aghajanian",
      "doi-asserted-by": "crossref",
      "first-page": "2039",
      "issue": "17",
      "journal-title": "J Clin Oncol",
      "key": "9739_CR3",
      "unstructured": "Aghajanian C, Blank SV, Goff BA, Judson PL, Teneriello MG, Husain A, Sovak MA, Yi J, Nycum LR (2012) OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer. J Clin Oncol 30(17):2039–2045. doi: 10.1200/JCO.2012.42.0505",
      "volume": "30",
      "year": "2012"
    },
    {
      "DOI": "10.1111/j.1749-6632.2012.06734.x",
      "author": "AY Ali",
      "doi-asserted-by": "crossref",
      "first-page": "58",
      "journal-title": "Ann N Y Acad Sci",
      "key": "9739_CR4",
      "unstructured": "Ali AY, Farrand L, Kim JY, Byun S, Suh JY, Lee HJ, Tsang BK (2012) Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum. Ann N Y Acad Sci 1271:58–67. doi: 10.1111/j.1749-6632.2012.06734.x",
      "volume": "1271",
      "year": "2012"
    },
    {
      "DOI": "10.1073/pnas.0502256102",
      "author": "D Xing",
      "doi-asserted-by": "crossref",
      "first-page": "6936",
      "issue": "19",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "9739_CR5",
      "unstructured": "Xing D, Orsulic S (2005) A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance. Proc Natl Acad Sci USA 102(19):6936–6941. doi: 10.1073/pnas.0502256102",
      "volume": "102",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.ygyno.2013.06.029",
      "author": "CJ Reade",
      "doi-asserted-by": "crossref",
      "first-page": "674",
      "issue": "3",
      "journal-title": "Gynecol Oncol",
      "key": "9739_CR6",
      "unstructured": "Reade CJ, Riva JJ, Busse JW, Goldsmith CH, Elit L (2013) Risks and benefits of screening asymptomatic women for ovarian cancer: a systematic review and meta-analysis. Gynecol Oncol 130(3):674–681. doi: 10.1016/j.ygyno.2013.06.029",
      "volume": "130",
      "year": "2013"
    },
    {
      "DOI": "10.1038/nature09267",
      "author": "H Guo",
      "doi-asserted-by": "crossref",
      "first-page": "835",
      "issue": "7308",
      "journal-title": "Nature",
      "key": "9739_CR7",
      "unstructured": "Guo H, Ingolia NT, Weissman JS, Bartel DP (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466(7308):835–840. doi: 10.1038/nature09267",
      "volume": "466",
      "year": "2010"
    },
    {
      "DOI": "10.1093/nar/gkm480",
      "author": "Z Yu",
      "doi-asserted-by": "crossref",
      "first-page": "4535",
      "issue": "13",
      "journal-title": "Nucl Acids Res",
      "key": "9739_CR8",
      "unstructured": "Yu Z, Li Z, Jolicoeur N, Zhang L, Fortin Y, Wang E, Wu M, Shen SH (2007) Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucl Acids Res 35(13):4535–4541. doi: 10.1093/nar/gkm480",
      "volume": "35",
      "year": "2007"
    },
    {
      "DOI": "10.1073/pnas.0802682105",
      "author": "K Jazdzewski",
      "doi-asserted-by": "crossref",
      "first-page": "7269",
      "issue": "20",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "9739_CR9",
      "unstructured": "Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A (2008) Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA 105(20):7269–7274. doi: 10.1073/pnas.0802682105",
      "volume": "105",
      "year": "2008"
    },
    {
      "DOI": "10.1093/carcin/bgn073",
      "author": "M Wu",
      "doi-asserted-by": "crossref",
      "first-page": "1710",
      "issue": "9",
      "journal-title": "Carcinogenesis",
      "key": "9739_CR10",
      "unstructured": "Wu M, Jolicoeur N, Li Z, Zhang L, Fortin Y, L’Abbe D, Yu Z, Shen SH (2008) Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs. Carcinogenesis 29(9):1710–1716. doi: 10.1093/carcin/bgn073",
      "volume": "29",
      "year": "2008"
    },
    {
      "DOI": "10.1006/geno.1994.1076",
      "author": "MJ Nicklin",
      "doi-asserted-by": "crossref",
      "first-page": "382",
      "issue": "2",
      "journal-title": "Genomics",
      "key": "9739_CR11",
      "unstructured": "Nicklin MJ, Weith A, Duff GW (1994) A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. Genomics 19(2):382–384. doi: 10.1006/geno.1994.1076",
      "volume": "19",
      "year": "1994"
    },
    {
      "author": "A Mustea",
      "first-page": "1099",
      "issue": "2A",
      "journal-title": "Anticancer Res",
      "key": "9739_CR12",
      "unstructured": "Mustea A, Sehouli J, Konsgen D, Stengel D, Sofroni D, Lichtenegger W (2003) Interleukin 1 receptor antagonist (IL-1RA) polymorphism in women with cervical cancer. Anticancer Res 23(2A):1099–1102",
      "volume": "23",
      "year": "2003"
    },
    {
      "author": "J Sehouli",
      "first-page": "1205",
      "issue": "11 Pt 1",
      "journal-title": "Cancer Epidemiol Biomark Prev",
      "key": "9739_CR13",
      "unstructured": "Sehouli J, Mustea A, Koensgen D, Lichtenegger W (2003) Interleukin-1 receptor antagonist gene polymorphism in epithelial ovarian cancer. Cancer Epidemiol Biomark Prev 12(11 Pt 1):1205–1208",
      "volume": "12",
      "year": "2003"
    },
    {
      "DOI": "10.1007/s10549-005-9079-6",
      "author": "KM Lee",
      "doi-asserted-by": "crossref",
      "first-page": "197",
      "issue": "2",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9739_CR14",
      "unstructured": "Lee KM, Park SK, Hamajima N, Tajima K, Choi JY, Noh DY, Ahn SH, Yoo KY, Hirvonen A, Kang D (2006) Genetic polymorphisms of interleukin-1 beta (IL-1B) and IL-1 receptor antagonist (IL-1RN) and breast cancer risk in Korean women. Breast Cancer Res Treat 96(2):197–202. doi: 10.1007/s10549-005-9079-6",
      "volume": "96",
      "year": "2006"
    },
    {
      "DOI": "10.1093/carcin/bgp283",
      "author": "Y Gao",
      "doi-asserted-by": "crossref",
      "first-page": "2064",
      "issue": "12",
      "journal-title": "Carcinogenesis",
      "key": "9739_CR15",
      "unstructured": "Gao Y, He Y, Ding J, Wu K, Hu B, Liu Y, Wu Y, Guo B, Shen Y, Landi D, Landi S, Zhou Y, Liu H (2009) An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1α 3′ untranslated region confers risk for hepatocellular carcinoma. Carcinogenesis 30(12):2064–2069. doi: 10.1093/carcin/bgp283",
      "volume": "30",
      "year": "2009"
    },
    {
      "DOI": "10.1002/mc.20706",
      "author": "ZH Yang",
      "doi-asserted-by": "crossref",
      "first-page": "208",
      "issue": "3",
      "journal-title": "Mol Carcinog",
      "key": "9739_CR16",
      "unstructured": "Yang ZH, Dai Q, Zhong L, Zhang X, Guo QX, Li SN (2011) Association of IL-1 polymorphisms and IL-1 serum levels with susceptibility to nasopharyngeal carcinoma. Mol Carcinog 50(3):208–214. doi: 10.1002/mc.20706",
      "volume": "50",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s10555-006-9004-4",
      "author": "RN Apte",
      "doi-asserted-by": "crossref",
      "first-page": "387",
      "issue": "3",
      "journal-title": "Cancer Metastasis Rev",
      "key": "9739_CR17",
      "unstructured": "Apte RN, Dotan S, Elkabets M, White MR, Reich E, Carmi Y, Song X, Dvozkin T, Krelin Y, Voronov E (2006) The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor–host interactions. Cancer Metastasis Rev 25(3):387–408. doi: 10.1007/s10555-006-9004-4",
      "volume": "25",
      "year": "2006"
    },
    {
      "DOI": "10.1038/sj.bjc.6602568",
      "author": "O Gubbay",
      "doi-asserted-by": "crossref",
      "first-page": "1927",
      "issue": "10",
      "journal-title": "Br J Cancer",
      "key": "9739_CR18",
      "unstructured": "Gubbay O, Guo W, Rae MT, Niven D, Langdon SP, Hillier SG (2005) Inflammation-associated gene expression is altered between normal human ovarian surface epithelial cells and cell lines derived from ovarian adenocarcinomas. Br J Cancer 92(10):1927–1933. doi: 10.1038/sj.bjc.6602568",
      "volume": "92",
      "year": "2005"
    },
    {
      "DOI": "10.1530/JOE-11-0081",
      "author": "G Papacleovoulou",
      "doi-asserted-by": "crossref",
      "first-page": "273",
      "issue": "3",
      "journal-title": "J Endocrinol",
      "key": "9739_CR19",
      "unstructured": "Papacleovoulou G, Critchley HO, Hillier SG, Mason JI (2011) IL1alpha and IL4 signalling in human ovarian surface epithelial cells. J Endocrinol 211(3):273–283. doi: 10.1530/JOE-11-0081",
      "volume": "211",
      "year": "2011"
    },
    {
      "DOI": "10.1677/joe.1.05754",
      "author": "MT Rae",
      "doi-asserted-by": "crossref",
      "first-page": "19",
      "issue": "1",
      "journal-title": "J Endocrinol",
      "key": "9739_CR20",
      "unstructured": "Rae MT, Niven D, Ross A, Forster T, Lathe R, Critchley HO, Ghazal P, Hillier SG (2004) Steroid signalling in human ovarian surface epithelial cells: the response to interleukin-1α determined by microarray analysis. J Endocrinol 183(1):19–28. doi: 10.1677/joe.1.05754",
      "volume": "183",
      "year": "2004"
    },
    {
      "DOI": "10.1186/1757-2215-3-3",
      "author": "M Keita",
      "doi-asserted-by": "crossref",
      "first-page": "3",
      "journal-title": "J Ovarian Res",
      "key": "9739_CR21",
      "unstructured": "Keita M, Bessette P, Pelmus M, Ainmelk Y, Aris A (2010) Expression of interleukin-1 (IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes. J Ovarian Res 3:3. doi: 10.1186/1757-2215-3-3",
      "volume": "3",
      "year": "2010"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-04-3877",
      "author": "S Frede",
      "doi-asserted-by": "crossref",
      "first-page": "4690",
      "issue": "11",
      "journal-title": "Cancer Res",
      "key": "9739_CR22",
      "unstructured": "Frede S, Freitag P, Otto T, Heilmaier C, Fandrey J (2005) The proinflammatory cytokine interleukin 1β and hypoxia cooperatively induce the expression of adrenomedullin in ovarian carcinoma cells through hypoxia inducible factor 1 activation. Cancer Res 65(11):4690–4697. doi: 10.1158/0008-5472.CAN-04-3877",
      "volume": "65",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.ygyno.2006.10.014",
      "author": "E Ioana Braicu",
      "doi-asserted-by": "crossref",
      "first-page": "680",
      "issue": "3",
      "journal-title": "Gynecol Oncol",
      "key": "9739_CR23",
      "unstructured": "Ioana Braicu E, Mustea A, Toliat MR, Pirvulescu C, Konsgen D, Sun P, Nurnberg P, Lichtenegger W, Sehouli J (2007) Polymorphism of IL-1α, IL-1β and IL-10 in patients with advanced ovarian cancer: results of a prospective study with 147 patients. Gynecol Oncol 104(3):680–685. doi: 10.1016/j.ygyno.2006.10.014",
      "volume": "104",
      "year": "2007"
    },
    {
      "DOI": "10.1046/j.1365-3083.1998.00300.x",
      "author": "S Santtila",
      "doi-asserted-by": "crossref",
      "first-page": "195",
      "issue": "3",
      "journal-title": "Scand J Immunol",
      "key": "9739_CR24",
      "unstructured": "Santtila S, Savinainen K, Hurme M (1998) Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1β production in vitro. Scand J Immunol 47(3):195–198",
      "volume": "47",
      "year": "1998"
    },
    {
      "author": "XF Zeng",
      "journal-title": "Tumour Biol",
      "key": "9739_CR25",
      "unstructured": "Zeng XF, Li J, Li SB (2013) A functional polymorphism in IL-1A gene is associated with a reduced risk of gastric cancer. Tumour Biol. doi: 10.1007/s13277-013-1034-2",
      "year": "2013"
    },
    {
      "DOI": "10.1016/S0029-7844(03)00123-6",
      "author": "S Tingulstad",
      "doi-asserted-by": "crossref",
      "first-page": "885",
      "issue": "5 Pt 1",
      "journal-title": "Obstet Gynecol",
      "key": "9739_CR26",
      "unstructured": "Tingulstad S, Skjeldestad FE, Halvorsen TB, Hagen B (2003) Survival and prognostic factors in patients with ovarian cancer. Obstet Gynecol 101(5 Pt 1):885–891",
      "volume": "101",
      "year": "2003"
    }
  ],
  "reference-count": 26,
  "references-count": 26,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-014-9739-y"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "A polymorphism at miRNA-122-binding site in the IL-1α 3′UTR is associated with risk of epithelial ovarian cancer"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "13"
}